Sartorius Stedim Biotech S.A.
SDMHF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19,221 | $19,701 | $18,341 | $18,326 |
| - Cash | $351 | $699 | $708 | $679 |
| + Debt | $3,008 | $2,969 | $2,933 | $2,870 |
| Enterprise Value | $21,878 | $21,971 | $20,566 | $20,516 |
| Revenue | $828 | $745 | $745 | $751 |
| % Growth | 11.2% | 0.1% | -0.9% | – |
| Gross Profit | $384 | $345 | $356 | $316 |
| % Margin | 46.4% | 46.3% | 47.9% | 42.1% |
| EBITDA | $255 | $201 | $256 | $133 |
| % Margin | 30.8% | 27% | 34.4% | 17.7% |
| Net Income | $75 | $69 | $86 | $46 |
| % Margin | 9.1% | 9.2% | 11.5% | 6.1% |
| EPS Diluted | 0.77 | 0.69 | 0.88 | 0.47 |
| % Growth | 11.6% | -21.6% | 87.2% | – |
| Operating Cash Flow | $71 | $125 | $120 | $285 |
| Capital Expenditures | -$158 | -$76 | -$65 | -$80 |
| Free Cash Flow | -$87 | $49 | $55 | $205 |